Norton Healthcare’s Post

We believe the goal of clinical research is to find new treatment options that will provide better outcomes for cancer patients. We conduct trials designed to evaluate new treatment options for patients who have been diagnosed with cancer. To see our current clinical trials, visit: https://loom.ly/0JVOT_A to see our current clinical trials! #Research #ClinicalResearch

Time To Talk: Diversity In Clinical Trials is an awareness campaign and platform dedicated to transforming cancer care for BIPOC patients and their families. Together, we can increase clinical trial participation and lead the way in cancer research. Find out more: https://bit.ly/4h9oGlu #TimetoTalkHOPA #BeTheAction #HealthEquity #CancerCareForAll

🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 Two of the six features of Zurich Accelerate are Virtual Consultant and Private Diagnostics Plus. These elements provide access to leading UK consultants such as cardiologists, neurologists and oncologists and diagnostic testing at over 100 private diagnostics centres in the UK. Why is this important? Many of the delays seen today can occur in the diagnostics & consultation stages before treatment even starts - delays here may unfortunately lead to poorer outcomes for the individual. Zurich Accelerate can help, with timely access to get the right tests done and obtain a confirmed diagnosis, so that a treatment plan can be devised. Wanting to learn more about Zurich Accelerate? Why not join one of our new Lunch and Learn sessions running from the 16th to 25th September - click here to register: https://lnkd.in/eKecUjKe Zurich UK #ZurichAccelerate 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀

Embrace diversity in cancer treatment options by exploring Phase 1 clinical trials led by experts like Dr. Wasif Saif at Karmanos Cancer Institute. These trials offer access to cutting-edge therapies that can make a difference in your cancer care journey. Stay informed, ask questions, and consider participating in clinical trials for personalized and innovative treatment approaches. #CancerResearch #ClinicalTrials #InnovativeTherapies #CancerCare #PatientAdvocacy BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X. Read more about this post here: https://lnkd.in/eqiKfkzj

May is National Cancer Research Month. Thanks to research-driven advances, there are more than 18 million people in the U.S. living with a history of a cancer diagnosis. This represents 5% of the U.S. population, up from 1.4% 50 years ago. Learn more in the AACR Cancer Progress Report: https://bit.ly/3UU3Wnp #NCRM24 #CancerResearchSavesLives

In June, we celebrate National #CancerSurvivorMonth, and recognize the strength and resilience of cancer survivors. We celebrate life, spread hope, and continue our commitment to cancer research to improve outcomes for all.     Learn from two of our #ORIEN Patient Advisory Council leaders, Barney Morris and Deborah Collyar, why they advocate for patients and cancer research.     Our work with our life sciences industry partners and academic cancer centers across the U.S. is critical to accelerating research and advancing precision medicine for patients with cancer. Together, we are changing the way cancer is studied, treated, and prevented.      #ResearchSavesLives #CelebrateSurvivorship 

🚨 Cancer Registry Inefficiencies Hurt Research Progress Did you know cancer data can take up to 426 days before it's available for research? This delay in reporting impacts the wider research community, causing missed opportunities for vital insights. Discover how improving reporting efficiency can accelerate cancer research in our latest infographic. 👇 Access the link below to download now. #CancerRegistry #CancerResearch #PatientCare https://hubs.li/Q02CJ6KK0

Did you know that in 2020, 75% of clinical trial participants were White, while only 11% were Latino, 8% Black, 6% Asian, and 1% Indigenous? These disparities limit our understanding of how cancer therapies work across diverse populations. Join the conversation with "Time to Talk Diversity in Clinical Trials," a campaign by HOPA and CMRignite, tackling the urgent need for equity in cancer research. 🌍💡 Let’s ensure all communities are represented in clinical trials. Register now to be part of this critical discussion: https://buff.ly/4gsQ1hM

Participants are needed for cancer clinical trials - especially BIPOC individuals. Diverse participation in cancer clinical trials helps ensure treatments are effective for broad populations. Plus, participants get the latest treatments before the become widely available. Find out how clinical trials have evolved to be safer and more accessible than ever: https://bit.ly/4hDx64Y

Here's a post from Memorial Sloan Kettering around some recent advancements in the detection and treatment of cancer. One thing that stands out to me is the use of AI in the identification of specific cancer types. With that information, treatments can be more accurately targeted to fight that particular cancer. Please feel free to share this information with those you may know struggling through this disease.